The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York city: Project ACHIEVE

AIDS

Volumn 10, Issue 13, 1996, Pages 1555-1561

  Koblin, Beryl A ^a   Taylor, Patricia E ^a   Avrett, Sam ^a   Stevens, Cladd E ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

Epidemiology; Gay men; Vaccine trials

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; BISEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UNITED STATES; VACCINATION;

EID: 0029850181     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199611000-00015     Document Type: Article

References (25)

1. Walker MC, Fast PE, Graham BS, Belshe R, Dolin R: Phase I/II preventive vaccine trials: conference summary. AIDS Res Hum Retroviruses 1995, 11:1279-1285.
2. Belshe RB, Graham BS, Keeter MC, et al.: Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. JAMA 1994, 272:475-480.
3. Cohen J: U.S. panel votes to delay real-world vaccine trials. Science 1994, 264:1839.
4. Hoff R: Progress towards readiness for efficacy trials in the United States: conference summary. AIDS Res Hum Retroviruses 1995, 11:1287-1290.
5. Douglas Jr JM, Judson FN, Parks JP, Buchbinder S, McKirnan D: Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials. AIDS Res Hum Retroviruses 1994, 10 (suppl 2):S257-S260.
6. Meyers K, Metzger DS, Navaline H, Woody GE, McLellan AT: HIV vaccine trials: will intravenous drug users enroll? Am J Public Health 1994, 84:761-766.
7. Nelson KE, Vlahov D, Galai N, Astemborski J, Solomon L: Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses 1994, 10 (suppl 2):S201-S205.
8. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. 1994, 6:8-9.
9. Van Griensven GJP, Koblin BA, Osmond D: Risk behaviour and HIV infection among younger homosexual men. AIDS 1994, 8 (suppl 1):S125-S130.
10. Dean L, Meyer I: HIV prevalence and sexual behavior in a cohort of New York City Gay Men (aged 18-24). J Acquir Immune Defic Syndr 1995, 8:208-211.
11. Hays RB, Kegeles SM, Coates TJ: High HIV risk-taking among young gay men. AIDS 1990, 4:901-907.
12. Stall R, Barrett D, Bye L, et al.: A comparison of younger and older gay men's HIV risk taking behaviors: the Communication Technologies 1989 cross-sectional survey. J Acquir Immune Defic Syndr 1992, 5:682-687.
13. Lemp GF, Hirozawa AM, Givertz D, et al.: Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men: the San Francisco/Berkeley Young Men's Survey. JAMA 1994, 272:449-454.
14. Osmond DH, Page K, Wiley J, et al.: HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health 1994, 84:1993-1937.
15. Prochaska JO, DiClemente CC, Norcross JC: In search of how people change: applications to addictive behaviors. Am Psychol 1992, 47:1102-1114.
16. Stevens CE, Taylor PE, Zang EA, et al.: Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA 1986, 255:2167-2172.
17. Centers for Disease Control: Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989, 38(suppl S7):1-7.
18. Kahn HA, Sempos CT: Statistical Methods in Epidemiology. New York: Oxford University Press; 1989:217-219.
19. Lee E: Statistical Methods for Survival Data Analysis. Belmont: Lifetime Learning Publications; 1980:306-318.
20. Davis CS: A computer program for regression analysis of repeated measures using generalized estimating equations. Computer Methods and Programs in Biomedicine 1993, 40:15-31.
21. Rida W, Fleming T, Stevens C: Alternative trial design: conference summary. AIDS Res Hum Retroviruses 1995, 1:1317-1319
22. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981, 1:377-385.
23. Stevens CE, Taylor PE, Rodriguez de Cordoba S, Zang EA, Rubinstein P: Sexual activity and human immunodeficiency virus type 1 infection in a cohort of homosexual men in New York City. In AIDS and Sex: An Integrated Biomedical and Biobehavioral Approach. Edited by Voeller B, Reinisch JM, Gottlieb M. New York: Oxford University Press; 1990:20-34.
24. Buchbinder S, Judson F, McKirnan D, et al.: HIV seroincidence and risk factors for HIV seroconversion in gay/bisexual men. Presented at the Seventh Annual Meeting of the National Cooperative Vaccine Development Croups for AIDS. Reston, November, 1994.
25. Kelly JA, Murphy DA, Sikkema KJ, Kalichman SC: Psychological interventions to prevent HIV infection are urgently needed: new priorities for behavioral research in the second decade of AIDS. Am Psychol 1993, 48:1023-1034.